Carla M. Canuso, MD

Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Adult Patients at Imminent Risk for Suicide: ASPIRE-1, a Phase 3 Randomized Study

Introduction: ASPIRE-1 is one of two global phase-3 studies in the registration program to evaluate efficacy and safety of esketamine nasal spray (ESK) vs placebo, with comprehensive stan...

Dong Jing Fu , MD, PhD;

Carla M. Canuso , MD;

Dawn F. Ionescu , MD;

Xiang Li , PhD;

Rosanne Lane , MD, MSc, MS;

Pilar Lim , MD, PhD;

David Hough , MD;

Husseini Manji , MD;

Wayne Drevets , MD;

11/22/2019

Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Adult Patients at Imminent Risk for Suicide: ASPIRE-2, a Phase 3 Randomized Study

Introduction: Efficacy and safety of esketamine (ESK) nasal spray were evaluated in ASPIRE-2 (NCT03097133), one of two phase-3 studies in the first global registration program in an under...

Dong Jing Fu , MD, PhD;

Carla M. Canuso , MD;

Dawn F. Ionescu , MD;

Rosanne Lane , MD, MSc, MS;

Pilar Lim , MD, PhD;

David Hough , MD;

Husseini Manji , MD;

Xin Qiu , MS;

Wayne Drevets , MD;

11/22/2019

Frequency of Rehospitalization After Hospitalization for Suicidal Ideation or Suicidal Behavior in Patients With Depression

Background: Rehospitalization due to suicidal ideation (SI) or suicidal attempt (SA) could be used to measure effectiveness of depression treatments in patients at risk for suicide. There...

Jenna Reps , PhD;

Carla M. Canuso , MD;

M. Soledad Cepeda , MD, PhD;

Martijn Schuemie , PhD;

Dave Kern , PhD;

11/22/2019